Conference on personalised cancer therapy

Barcelona: 3-4 December 2012

The organisers of the IDIBELL Cancer Conference (ICC) on Personalized Cancer Medicine – Manel Esteller, George Thomas, Cristina Muñoz- Pinedo and Sara Kozma – will present 21speakers for the event, all leading oncologists and cancer researchers, particularly those working in the study of genetic and epigenetic defects leading to the selection of cancer patients for new drug therapies. The meeting aims to highlight the latest understanding of biological mechanisms and natural history of cancer, thus providing novel targets for therapy, as well as to discuss the molecular mechanisms involved in the stratification of oncology patents according to the recently described molecular markers. Special focus: Epigenetics and DNA Repair and the metabolism and cell signalling areas with the updated clinical applications. Details: http://bocemtium.com

05.11.2012

News • Circulating tumor DNA status

Colorectal cancer: blood test shows who benefits from chemotherapy after surgery

A blood test for ctDNA may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit from chemotherapy after surgery, according to new research.

News • Side-effects of cancer care

Survey reveals major gaps in cardio-oncology training

A new survey highlights major gaps in cardio-oncology training, despite its increasing clinical importance for prevention and early management of cardiovascular complications in patients with cancer.

News • Promising results for low-risk women

Radiotherapy advances may let breast cancer patients skip surgery

Due to advances in radiation therapy, some breast cancer patients may be able to omit surgery following ablative radiation, according to new results of a Phase 2 trial.

Related articles